Independent intelligence for surgical AI
AI in neurosurgery: the research, the anatomy, and the evidence behind the tools.Research. Anatomy. Evidence.
Latest Brief · Issue 14 · Oct 12, 2026 · 11 min readIssue 14 · Oct 12, 2026
Evidence on risk models, preference influence, and surgical data abstraction points to one architecture: connect prediction, communication, adjudication, outcomes, and recalibration.Prediction and consent become defensible when outcomes flow back into validation and recalibration.
Read the BriefNeurosurgery Visual Atlas
Explore mechanisms, imaging, and operative anatomy through AI-assisted educational illustrations. Review status is shown for each guide.
Featured visual guide
Illustration preview · Full-size figures inside AI-assisted illustration
Neurovascular compression, synthetic MRI teaching views, and the decision boundary for microvascular decompression.
Illustration preview · Full-size figures inside AI-assisted illustration
Developmental hypotheses, cyst expansion, and the tumor–cord interface that can limit safe resection.
Illustration preview · Full-size figures inside AI-assisted illustration
Venous congestive myelopathy, perimedullary flow voids, and why 3D SPACE can suggest—but not prove—the shunt level.
Neurosurgery.ai Index
Eight 2025–2026 FDA records: cleared uses, public evidence, and the clinical limits the regulatory files do not resolve. Inclusion is not endorsement. Three recent FDA records, with intended uses and evidence limits. Inclusion is not endorsement.
Scroll the table horizontally to view all columns.
| Record | Workflow | Status | Evidence boundary |
|---|---|---|---|
| Stealth AXiS Cranial | Cranial navigation and planning | FDA K253379 · 2026 | Accuracy V&V; no outcome-superiority claim. |
| Acorn 3D | Spine planning and simulation | FDA K260322 · 2026 | Bench testing; no patient-outcome benefit established. |
| JLK-NCCT | ICH and LVO notification | FDA K252421 · 2026 | Triage only; negative output does not exclude disease. |